NCT00122486View on ClinicalTrials.gov

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

March 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Tenofovir Disoproxil Fumarate

Trial Locations (3)

Unknown

Care and Health Program, Douala

Virtual Access, Tema

University of College Hospital, Ibadan

All Listed Sponsors
lead

FHI 360

OTHER

NCT00122486 - Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV | Biotech Hunter | Biotech Hunter